Mebeverine Hydrochloride Syri

Mebeverine Hydrochloride, the active ingredient in Mebeverine Hydrochloride Syri, is an antispasmodic presented as a standard strength oral tablet for oral use. It treats irritable bowel syndrome and functional bowel disorders in adults.

GNH USA supplies Mebeverine Hydrochloride Syri as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mebeverine Hydrochloride acts on gastrointestinal smooth muscle to relieve spasm and related discomfort. - Irritable bowel syndrome: reduces abdominal pain, cramping and irregular bowel movements. - Functional bowel disorders: improves stool consistency and eases discomfort associated with dysmotility. - Gastrointestinal spasm: relaxes smooth muscle, helping to normalize transit and lessen urgency.

Mebeverine Hydrochloride is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild, transient stomach upset. - Headache: occasional dull or throbbing pain. - Dizziness: brief light‑headed sensation. - Dry mouth: reduced salivation. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling or difficulty breathing. - Palpitations: irregular or rapid heartbeat. - Severe abdominal pain: persistent or worsening discomfort. - Hepatic dysfunction: abnormal liver enzyme levels. - Blood dyscrasias: unexplained bruising or bleeding.

Before using Mebeverine Hydrochloride, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Liver impairment: use with caution; monitor hepatic function if indicated. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Drug interactions: review concomitant medications with a pharmacist. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Mebeverine Hydrochloride may interact with other medicines; awareness of the type of interaction helps manage risk.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase plasma levels of mebeverine. - Anticholinergic agents: combined effect could exacerbate constipation.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): monitor for enhanced gastrointestinal side effects. - Antihistamines: may increase risk of dry mouth. - Diuretics: watch for electrolyte disturbances. - Anticoagulants: observe for any changes in bleeding tendency.